BAY X 7195

Drug Profile

BAY X 7195

Latest Information Update: 09 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bayer
  • Class
  • Mechanism of Action Leukotriene C4 receptor antagonists; Leukotriene D4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Asthma

Most Recent Events

  • 10 Sep 1998 A study in asthmatic patients has been added to the therapeutic trials section
  • 01 Dec 1997 Phase-II clinical trials for Asthma in USA (Inhalation)
  • 01 Dec 1997 Phase-II clinical trials for Asthma in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top